Jardiance 10 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FY9CV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,166
Award facts
- Contract value 100% obligated
- $63,165.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $63,165.85 delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed-price contract. The award, issued on August 8, 2025, with completion targeted for August 11, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. No set-aside designation was used in this competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and maintains an extensive portfolio of brand-name and generic medications to support military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (contract SPE2DX), which extends through December 2026 and provides global pharmaceutical support across multiple therapeutic domains for Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Jardiance, a diabetes management medication, aligns with AmerisourceBergen's demonstrated capability in supplying specialty pharmaceuticals and chronic disease management treatments. The firm fixed-price delivery order structure reflects DLA's standard approach for pharmaceutical procurement through its medical supply chain, enabling efficient fulfillment of healthcare requirements across the Department of Defense enterprise.
Quick answers
Who was awarded contract SPE2DB25FY9CV?
SPE2DB25FY9CV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FY9CV worth?
The government has obligated $63,166 on SPE2DB25FY9CV.
Is contract SPE2DB25FY9CV an order under another contract?
Yes. SPE2DB25FY9CV is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY9CV competed?
The extent of competition for SPE2DB25FY9CV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award